{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "EGFR",
        "Protein_Change": {
          "ref": "L",
          "alt": "R",
          "position": "858"
        },
        "variant_string_id": "EGFR L858R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper defines Lewy body formation as a key component of Parkinson's disease, where Î±Synuclein forms amyloid conformation fragments.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assays likely assess protein folding or conformation changes.",
          "judgment": "Yes",
          "reasoning": "The general class of enzyme activity assay is applicable."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type protein, loss-of-function mutants) and replication are mentioned.",
          "judgment": "Yes",
          "reasoning": "The specific instance of the assay for these mutations is valid."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses may include OddsPath calculations.",
          "judgment": "Yes",
          "reasoning": "The statistical analysis for each mutation's assay is mentioned."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "This variant provides strong evidence for its role in Lewy body formation and Parkinson's disease neurodegeneration."
    }
  ]
}